1 Min Read
Dec 13 (Reuters) - Intrexon Corp :
* Intrexon Corp - initial studies have validated efficacy of dsRNA for insect control applications using its proprietary ActoBiotics platform Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.